Journal
SENSORS
Volume 17, Issue 7, Pages -Publisher
MDPI AG
DOI: 10.3390/s17071495
Keywords
Digital Microfluidics; nucleic acid amplification; point-of-care diagnostics
Funding
- FEDER funds through the COMPETE Program [POCI-01-0145-FEDER-007728]
- National Funds through FCT-Portuguese Foundation for Science and Technology [UID/CTM/50025/2013, UID/Multi/04378/2013]
- Water JPI Proj TRACE [281715]
- [SFRH/BPD/124311/2016]
- Fundação para a Ciência e a Tecnologia [SFRH/BPD/124311/2016] Funding Source: FCT
Ask authors/readers for more resources
Digital Microfluidics (DMF) has emerged as a disruptive methodology for the control and manipulation of low volume droplets. In DMF, each droplet acts as a single reactor, which allows for extensive multiparallelization of biological and chemical reactions at a much smaller scale. DMF devices open entirely new and promising pathways for multiplex analysis and reaction occurring in a miniaturized format, thus allowing for healthcare decentralization from major laboratories to point-of-care with accurate, robust and inexpensive molecular diagnostics. Here, we shall focus on DMF platforms specifically designed for nucleic acid amplification, which is key for molecular diagnostics of several diseases and conditions, from pathogen identification to cancer mutations detection. Particular attention will be given to the device architecture, materials and nucleic acid amplification applications in validated settings.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available